ESC Premium Access

GENECHOC study: a study designed to identify the genetic variants involved in appropriate shock in primary prevention; clinical description of the patients

Congress Presentation

About the speaker

Professor Vincent Probst

University Hospital of Nantes, Nantes (France)
8 presentations
0 follower

10 more presentations in this session

Sudden cardiac arrest in patients without overt heart disease - Clinical assessment, family screening and genetic testing by next generation sequencing.

Speaker: Doctor M. Stepien-Wojno (Warsaw, PL)


Validation of the indication for implantable cardioverter defibrillator in Brugada syndrome in the J Wave Syndromes Consensus Conference

Speaker: Professor M. Takagi (Moriguchi, JP)


Drug-testing using human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome

Speaker: Mrs Z. Zhao (Mannheim, DE)


Late gadolinium enhancement at cardiac magnetic resonance accurately predicts arrhythmias in patients with non-ischemic cardiomyopathy

Speaker: Doctor C. Raineri (Turin, IT)


Ranolazine reduces levosimendan-mediated atrial fibrillation in an experimental whole-heart model

Speaker: Professor G. Frommeyer (Munster, DE)


Access the full session

Poster Session 3 - Arrhythmia mechanisms - General

Speakers: Professor V. Probst, Doctor M. Stepien-Wojno, Professor M. Takagi, Mrs Z. Zhao, Doctor C. Raineri...

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb